Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_3
1
33%
Ph phase_2
2
67%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (66.7%)
Phase 31 (33.3%)

Trials by Status

completed267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_3

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

NCT06708299
completedphase_2

Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)

NCT05494788
completedphase_2

Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

NCT05180240

Clinical Trials (3)

Showing 3 of 3 trials
NCT06708299Phase 3

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

Recruiting
NCT05494788Phase 2

Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)

Completed
NCT05180240Phase 2

Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3